Not Signed In -
Biopsychosocial model |
|
|
Clinical Trial: A Laboratory Model for Heroin Abuse Medications - 8
This study is no longer recruiting patients.
Purpose
The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Heroin Dependence Opioid-Related Disorders Substance-Related Disorders | Drug: Methadone | Phase II |
MedlinePlus related topics: Drug Abuse; Heroin Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: A Laboratory Model for Heroin Abuse Medications
Further Study Details:
Expected Total Enrollment: 37
Study start: August 1995; Study completion: August 1997
Eligibility
Ages Eligible for Study: 18 Years - 45 Years, Genders Eligible for Study: Both
Criteria
Please contact site for information.
Location Information
New York
Columbia University, New York, New York, 10023, United States
Study chairs or principal investigators
Herbert Kleber, M.D., Principal Investigator, New York State Psychiatric Institute
More Information
Study ID Numbers: NIDA-09236-8; P50-09236-8
Record last reviewed: August 1995
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000273
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: August 1995
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000273
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
